4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000141
Chairperson & CEO sold 9,500 shares at an average $504.12 ($4,789,152)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-14 | Sale : show line 2 in the form 10b5-1 | −1,580 | $502.15 | $793,399 | 332,363 | I |
| 2026-09-14 | Sale : show line 3 in the form 10b5-1 | −2,358 | $503.44 | $1,187,113 | 330,005 | I |
| 2026-09-14 | Sale : show line 4 in the form 10b5-1 | −2,722 | $504.47 | $1,373,180 | 327,283 | I |
| 2026-09-14 | Sale : show line 5 in the form 10b5-1 | −2,400 | $505.25 | $1,212,609 | 324,883 | I |
| 2026-09-14 | Sale : show line 6 in the form 10b5-1 | −440 | $506.48 | $222,851 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $504.12 · $4,789,152 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-14 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −9,500 | 442,410 | I |
Loading xslF345X06/primarydocument.xml…